Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro

A M Dvorak, R A Seder, W E Paul, E S Morgan, S J Galli, A M Dvorak, R A Seder, W E Paul, E S Morgan, S J Galli

Abstract

We assessed the ultrastructure and the cell-surface expression of receptors for immunoglobulin E (Fc epsilon R), and c-kit, the receptor for stem cell factor (SCF), in mouse basophils and mast cells present in short-term cultures of mouse bone marrow cells in interleukin-3 (IL-3) with or without SCF. Basophils did not develop increased numbers of cytoplasmic granules and underwent apoptosis in cultures containing IL-3 and SCF, whereas mast cells thrived and developed increased numbers of granules. Basophils were nearly all Fc epsilon R+ c-kit- when sorted after culture in IL-3 and SCF; most mast cells were Fc epsilon R+ c-kit+. However, a second population of Fc epsilon R+ c-kit- mast cells was present after culture in IL-3 and SCF. These c-kit receptor-negative mast cells were less mature than c-kit+ mast cells and contained significantly fewer cytoplasmic granules than the c-kit+ mast cells present in the same cultures (P < 0.001). Thus, mouse basophils express little or no c-kit receptor on their surface, nor can they survive for long periods in SCF-supplemented cultures. By contrast, mouse mast cells seem to express the Fc epsilon R early in their development, even before they express detectable c-kit receptors on their surface. IL-3 promotes cytoplasmic granule formation in immature mast cells, but even more granules are formed when c-kit receptor-positive immature mast cells are cultured in both SCF and IL-3.

References

    1. Am J Pathol. 1987 Mar;126(3):535-45
    1. Nature. 1984 Jan 19-25;307(5948):233-7
    1. Proc Natl Acad Sci U S A. 1984 Feb;81(4):1070-4
    1. Proc Natl Acad Sci U S A. 1988 Nov;85(21):7897-901
    1. Lab Invest. 1989 Jul;61(1):116-32
    1. Lab Invest. 1990 Jan;62(1):5-33
    1. J Exp Med. 1990 May 1;171(5):1497-508
    1. Cell. 1990 Oct 5;63(1):167-74
    1. Cell. 1990 Oct 5;63(1):175-83
    1. Cell. 1990 Oct 5;63(1):195-201
    1. Cell. 1990 Oct 5;63(1):203-11
    1. Cell. 1990 Oct 5;63(1):213-24
    1. Cell. 1990 Oct 5;63(1):225-33
    1. Cell. 1990 Oct 5;63(1):235-43
    1. Cell. 1990 Oct 5;63(1):5-6
    1. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2835-9
    1. Mol Immunol. 1991 Oct;28(10):1149-54
    1. J Immunol. 1992 Jul 15;149(2):599-608
    1. N Engl J Med. 1993 Jan 28;328(4):257-65
    1. Am J Pathol. 1993 Apr;142(4):965-74
    1. J Immunol. 1980 Jun;124(6):2728-37
    1. Nature. 1981 May 28;291(5813):332-4
    1. Blood. 1982 Jun;59(6):1279-85
    1. J Cell Biol. 1982 Nov;95(2 Pt 1):435-44
    1. J Exp Med. 1983 Mar 1;157(3):843-61
    1. Lab Invest. 1993 Jun;68(6):708-15

Source: PubMed

3
Subskrybuj